Zegocractin is under clinical development by CalciMedica and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Diseases of the pancreas can mimic other medical conditions, and accurate diagnosis is crucial. With the increase in access ...

significantly reduces triglyceride levels in patients with severe hypertriglyceridemia (sHTG). The SHASTA-2 trial assessed ...

Pancreatitis in children, often mistaken for minor digestive issues, can cause severe abdominal pain and requires timely ...